"Navigating the labyrinth of health insurance can be a deadly ordeal, as demonstrated by Kenney Blewett’s tragic death, a stark reminder of how bureaucratic red tape can have life-altering, and in this case, fatal consequences."
The American healthcare system, despite its advanced medical capabilities, is frequently hampered by a complex web of insurance regulations and administrative processes. For many patients, the journey to accessing necessary medical care is fraught with delays, denials, and overwhelming confusion. This was tragically underscored by the case of Kenney Blewett, a man suffering from severe chronic obstructive pulmonary disease (COPD), whose life was cut short following a delay in receiving a crucial medication, a delay that his grieving wife believes may have directly contributed to his decision to end his life. This narrative serves as a poignant illustration of the profound human cost of insurance-related obstacles in healthcare.
Kenney Blewett, a resident of Kyle, Texas, had lived with lung disease for over a decade. However, in the year leading up to his death in June, his condition worsened significantly, marked by frequent and terrifying flare-ups that left him struggling for breath. His wife, Cindy, described these episodes as "the scariest thing in the world," noting their increasing frequency and duration, even though they typically lasted only a few minutes. The severity of his illness extended beyond these acute episodes; simple daily tasks, such as taking out the trash, left him profoundly winded. This debilitating decline led him to rarely leave the house and resulted in a significant weight loss of 45 pounds, a symptom one of his doctors ominously likened to cancer. It was evident that Blewett’s health, exacerbated by decades of smoking, was in steep decline.
In response to Kenney’s deteriorating condition, his pulmonologist prescribed a new medication on June 2, intended to alleviate his breathing difficulties. This prescription, however, was not immediately filled. Two days after his doctor’s appointment, the Blewetts received an email from Walgreens, the dispensing pharmacy, stating that the medication’s delivery was delayed due to an "insurance issue that we’re working to resolve." Cindy Blewett expressed her profound sorrow, stating, "He was hopeful that it would work. I wish we had the chance to find out." Her husband’s death, just months after celebrating their 60th wedding anniversary, highlighted the devastating impact of these systemic failures.
The challenges faced by the Blewetts are not isolated incidents. Insurance delays and denials have become a pervasive and deeply problematic aspect of the American healthcare landscape. A January KFF Health Tracking Poll revealed that nearly 7 out of 10 adults consider these issues a "major problem." This widespread frustration has prompted efforts to address the problem, including a highly publicized industry pledge in June 2025, initiated by the Trump administration and signed by numerous major health insurers. The pledge aimed to dismantle barriers that impede patient access to doctor-recommended care. However, the voluntary nature of this pledge, lacking any enforcement mechanisms or penalties for non-compliance, has led to skepticism. A subsequent report by KFF Health News in July indicated that some insurers who signed the pledge were not fully implementing the proposed initiatives as originally outlined, suggesting a continued gap between commitment and action.
In the absence of comprehensive federal reform, lawmakers in many states, including Texas, have attempted to regulate the insurance industry to mitigate delays and denials. However, these state-level efforts often fall short, as a significant portion of health insurance plans, including traditional Medicare policies and employer-sponsored offerings—which collectively cover more than half of the American population—operate beyond the purview of state jurisdiction. This creates a fragmented and confusing regulatory environment.
The complexity of navigating these insurance rules and regulations extends even to healthcare professionals. Medical office staff and pharmacy employees frequently find themselves bewildered by the patchwork of state and federal mandates. This confusion is poised to intensify with the increasing integration of artificial intelligence into the claims processing and approval stages, as highlighted by KFF Health News’s reporting on AI’s growing role in coverage decisions. Matt Toresco, CEO of ArchÅ, a patient advocacy and consulting firm, lamented, "It’s just gotten completely out of hand," emphasizing the critical need for enhanced patient support in overcoming these insurance-related hurdles.
Cindy Blewett’s experience vividly illustrates the arduous and often overwhelming task patients and their caregivers face when trying to navigate these intricate healthcare complexities. She diligently sought answers from multiple entities, including Medicare, Kenney’s private Part D drug plan, his pulmonologist’s office, and Walgreens, yet remained uncertain about the precise cause of the medication delay and how it could have been prevented. The agonizing question lingered: if the COPD flare-up on the evening of June 7 could have been averted with timely medication, would her husband still have chosen to end his life that night?
During the initial days of June, Kenney repeatedly inquired about the status of his prescription, a liquid medication intended for nebulizer administration. Cindy initially harbored no immediate concerns about the delay, attributing it partly to the recent acquisition of Walgreens by a private equity firm, which had reportedly led to widespread job cuts and a perceived slowdown in pharmacy operations at their local Kyle branch. When she contacted the pharmacy for more information, a Walgreens employee informed her that the prescription required prior authorization, a common practice where medical providers must obtain approval from insurers before dispensing certain treatments.
However, Cindy was uncertain which of Kenney’s multiple insurance policies mandated prior authorization for this specific medication. Kenney was covered by traditional Medicare Parts A and B, along with a private Part D plan through Wellcare Value Script for drug costs and a Medicare supplement (Medigap) plan through Blue Cross and Blue Shield of Texas for other out-of-pocket expenses. She initially presumed his Part D plan was the source of the prior authorization requirement. Yet, because the medication was an inhaled liquid, it fell under Medicare Part B’s durable medical equipment benefit, not Part D.
The Medicare agency informed Cindy over the phone that they had no record of the prescription being billed to Kenney’s Part B policy. Representatives for Centene, Wellcare Value Script’s parent company, declined to comment on the matter. Following Kenney’s death, Cindy’s attempts to clarify the situation at Walgreens were met with conflicting explanations from the pharmacy staff. She recalled one employee suggesting that the prescription had been submitted to Medicare Part B but lacked a necessary diagnostic code from the physician.
Walgreens spokesperson Carmen Lopez stated that the company could not comment on individual cases. Subsequently, a Walgreens district pharmacy supervisor contacted Cindy, explaining that the pharmacy had attempted to process the prescription through Part B on June 2, the same day as the pulmonologist’s appointment. However, the prescription was reportedly missing a diagnostic code from the physician. The supervisor claimed that Walgreens had faxed a request for this code to the pulmonologist’s office later that day.
In contrast, an employee at Kenney’s pulmonologist’s practice, Rajesh Shetty of LungDocs, informed Cindy that they had not received any fax from Walgreens requesting a diagnostic code for the prescription. Kenney’s Medigap plan was also ruled out as a source of the delay, as these policies do not typically require prior authorization. Cindy expressed her frustration, stating, "Short of getting attorneys involved, I’m not sure how to find out what really happened."
The confusion surrounding the distinctions between Medicare Part B and Part D coverage is a common issue, according to Mike Hess, senior director of advocacy and regulatory affairs at the COPD Foundation. He noted, "Medicare has gotten to be so complex and convoluted over the years," leading to misunderstandings even among healthcare professionals. The increasing reliance on artificial intelligence in the preapproval process is expected to further complicate matters for Medicare beneficiaries and their physicians.
While traditional Medicare historically utilized prior authorization sparingly compared to Medicare Advantage plans, a pilot program launched in January in six states—Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington—is testing the use of AI for preapproving certain healthcare services. CMS Administrator Mehmet Oz described the program’s aim as "rooting out waste in Original Medicare." However, physicians and patients report that this initiative is creating additional administrative burdens and leading to inappropriate denials. Although COPD medications are not currently subject to prior authorization under this pilot program, industry experts anticipate its expansion to include more services and states.
On the evening of June 7, hours after Kenney’s final severe COPD flare-up, Cindy was on their back porch when she heard a gunshot. Initially mistaking the sound for a falling picture frame, she soon discovered her husband’s body in their bedroom. "I can’t tell you how horrible it was," she recounted. Cindy revealed that Kenney had long struggled with his mental health and had a previous suicide attempt. His worsening physical health exacerbated his psychological distress. A note left by Kenney confirmed this, expressing his love for his wife and family but stating his health was too poor to continue living.
Tragically, another prescribed COPD medication, ordered directly from the manufacturer by Kenney’s pulmonologist on June 2, arrived several weeks after his death. "Perhaps, just perhaps," Cindy reflected with profound sadness, "if he had received both medications in a timely manner, he would be here today, and we would have had many more years together." Her words underscore the devastating reality that administrative failures in healthcare can have irreversible and tragic consequences, leaving behind a legacy of grief and unanswered questions.
